OZURIFTAMAB VEDOTIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 00:55:05 GMT 2025` Edited by `admin` on `Wed Apr 02 00:55:05 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	BPM6YN0KLI
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BA-3021

Preferred Name

English

OZURIFTAMAB VEDOTIN

Official Name

English

CAB-ROR2-ADC (BA-3021)

Common Name

English

BA3021

Code

English

Ozuriftamab vedotin [WHO-DD]

Common Name

English

OZURIFTAMAB VEDOTIN [USAN]

Common Name

English

IMMUNOGLOBULIN G1 (DE-452-LYSINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR ROR2) (HUMAN-MUS MUSCULUS MONOCLONAL BA302 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BA302 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOX

Common Name

English

ozuriftamab vedotin [INN]

Common Name

English

BA-302 CONJUGATED TO MONOMETHYL AURISTATIN E

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

663018

Created by admin on Wed Apr 02 00:55:05 GMT 2025 , Edited by admin on Wed Apr 02 00:55:05 GMT 2025

Code System Code Type Description

USAN

JK-84

Created by admin on Wed Apr 02 00:55:05 GMT 2025 , Edited by admin on Wed Apr 02 00:55:05 GMT 2025

PRIMARY

NCI_THESAURUS

C155812

Created by admin on Wed Apr 02 00:55:05 GMT 2025 , Edited by admin on Wed Apr 02 00:55:05 GMT 2025

PRIMARY

SMS_ID

300000039974

Created by admin on Wed Apr 02 00:55:05 GMT 2025 , Edited by admin on Wed Apr 02 00:55:05 GMT 2025

PRIMARY

CAS

2460400-11-5

Created by admin on Wed Apr 02 00:55:05 GMT 2025 , Edited by admin on Wed Apr 02 00:55:05 GMT 2025

PRIMARY

INN

11952

Created by admin on Wed Apr 02 00:55:05 GMT 2025 , Edited by admin on Wed Apr 02 00:55:05 GMT 2025

PRIMARY

FDA UNII

BPM6YN0KLI

Created by admin on Wed Apr 02 00:55:05 GMT 2025 , Edited by admin on Wed Apr 02 00:55:05 GMT 2025

PRIMARY

From	To
1_22	1_96
2_22	2_96
2_149	2_205
2_225	4_213
2_266	2_326
1_149	1_205
2_372	2_430
3_23	3_87
3_133	3_193
4_23	4_87
4_133	4_193
1_225	3_213
1_231	2_231
1_234	2_234
1_266	1_326
1_372	1_430

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_302
N	2_302

Related Record Type Details


					BPM6YN0KLI

OZURIFTAMAB VEDOTIN

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION		RESIDUE_SPECIFIC		Amount:	Cysteinyl vedotin	6603L01WUR

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL